Document Type : Review Article

Authors

1 Department of Radiology and Radiobiology, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran

2 Ionizing and Non-Ionizing Radiation Protection Research Center (INIRPRC), Shiraz University of Medical Sciences, Shiraz, Iran

3 Student Research Committee, Fasa University of Medical Sciences, Fasa, Iran

Abstract

Normal skin is composed of epidermis and dermis. Skin is susceptible to radiation damage because it is a continuously renewing organ containing rapidly proliferating mature cells. Radiation burn is a damage to the skin or other biological tissues caused by exposure to radiofrequency energy or ionizing radiation. Acute skin reaction is the most frequently occurring side effect of radiation therapy. Generally, any chemical/biological agent given before or at the time of irradiation to prevent or ameliorate damage to normal tissues is called a radioprotector. Melatonin is a highly lipophilic substance that easily penetrates organic membranes and therefore is able to protect important intracellular structures including mitochondria and DNA against oxidative damage directly at the sites where such a kind of damage would occur. Melatonin leads to an increase in the molecular level of some important antioxidative enzymes such as superoxide, dismotase and glutation-peroxidase, and also a reduction in synthetic activity of nitric oxide. There is a large body of evidence which proves the efficacy of Melatonin in ameliorating UV and X ray-induced skin damage. We propose that, in the future, Melatonin would improve the therapeutic ratio in radiation oncology and ameliorate skin damage more effectively when administered in optimal and non-toxic doses.

Keywords

  1. McQuestion M. Evidence-based skin care management in radiation therapy. Semin Oncol Nurs. 2006;22(3):163-73. doi.org/10.1016/j.soncn.2006.04.004. PubMed PMID: 16893745.
  2. Ringborg U, Bergqvist D, Brorsson B, Cavallin-Stahl E, Ceberg J, Einhorn N, et al. The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of radiotherapy for cancer including a prospective survey of radiotherapy practice in Sweden 2001--summary and conclusions. Acta Oncol. 2003;42:357-65. doi.org/10.1080/02841860310010826. PubMed PMID: 14596499.
  3. Ryan JL. Ionizing radiation: the good, the bad, and the ugly. J Invest Dermatol. 2012;132:985-93. doi.org/10.1038/jid.2011.411. PubMed PMID: 22217743. PubMed PMCID: 3779131.
  4. Waghmare CM. Radiation burn--from mechanism to management. Burns. 2013;39(2):212-9. doi.org/10.1016/j.burns.2012.09.012. PubMed PMID: 23092699.
  5. Porock D, Nikoletti S, Kristjanson L. Continuing Education: Management of Radiation Skin Reactions Literature Review and Clinical Application. Plastic Surgical Nursing. 1999;19(4):185-92. doi.org/10.1097/00006527-199919040-00004.
  6. Balter S, Hopewell JW, Miller DL, Wagner LK, Zelefsky MJ. Fluoroscopically guided interventional procedures: a review of radiation effects on patients’ skin and hair. Radiology. 2010;254(2):326-41. doi.org/10.1148/radiol.2542082312. PubMed PMID: 20093507.
  7. Koenig TR, Wolff D, Mettler FA, Wagner LK. Skin injuries from fluoroscopically guided procedures: part 1, characteristics of radiation injury. AJR Am J Roentgenol. 2001;177(1):3-11. doi.org/10.2214/ajr.177.1.1770003. PubMed PMID: 11418388.
  8. El-Missiry M, Othman A, Alabdan M. Melatonin for protection against ionizing radiation: INTECH Open Access Publisher; 2012.
  9. Rezaeyan A, Fardid R, Haddadi G H, Takhshid M A. Evaluating Radioprotective Effect of Hesperidin on Acute Radiation Damage in the Lung Tissue of Rats. J Biomed Phys Eng. 2016; 6(3):165-174. PubMed PMID: 27853724; PubMed Central PMCID: PMC5106549.
  10. Fardid R., Ghorbani Zh., Haddadi Gh., Behzad-Behbahani A., Arabsolghar R., Kazemi E., Okhovat M. A., Hosseinimehr S. J. Effects of Hesperidin as a Radioprotector on Apoptosis in Rat Peripheral Blood Lymphocytes after Gamma Radiation. J Biomed Phys Eng. 2016; 6(4):217-228. Published online 2016 Dec 1. PMCID: PMC5219572.
  11. Brady LW. Radiation sensitizers: their use in the clinical management of cancer: Masson Pub. USA; 1980.
  12. Vardy J, Wong E, Izard M, Clifford A, Clarke SJ. Life-threatening anaphylactoid reaction to amifostine used with concurrent chemoradiotherapy for nasopharyngeal cancer in a patient with dermatomyositis: a case report with literature review. Anticancer Drugs. 2002;13(3):327-30. doi.org/10.1097/00001813-200203000-00015. PubMed PMID: 11984077.
  13. Shirazi A, Haddadi GH, Ghazi-Khansari M, Abolhassani F, Mahdavi SR, Eshraghyan MR. Evaluation of melatonin for prevention of radiation myelopathy in irradiated cervical spinal cord. Cell J. 2009;11(1):43-8.
  14. Vijayalaxmi, Reiter RJ, Tan DX, Herman TS, Thomas CR, Jr. Melatonin as a radioprotective agent: a review. Int J Radiat Oncol Biol Phys. 2004;59(3):639-53. doi.org/10.1016/j.ijrobp.2004.02.006. PubMed PMID: 15183467.
  15. Slominski A, Tobin DJ, Zmijewski MA, Wortsman J, Paus R. Melatonin in the skin: synthesis, metabolism and functions. Trends Endocrinol Metab. 2008;19(1):17-24. doi.org/10.1016/j.tem.2007.10.007. PubMed PMID: 18155917.
  16. Fischer TW, Slominski A, Zmijewski MA, Reiter RJ, Paus R. Melatonin as a major skin protectant: from free radical scavenging to DNA damage repair. Exp Dermatol. 2008;17(9):713-30. doi.org/10.1111/j.1600-0625.2008.00767.x. PubMed PMID: 18643846.
  17. Reiter RJ, Tan DX, Manchester LC, Qi W. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence. Cell Biochem Biophys. 2001;34(2):237-56. doi.org/10.1385/CBB:34:2:237. PubMed PMID: 11898866.
  18. Slominski A, Fischer TW, Zmijewski MA, Wortsman J, Semak I, Zbytek B, et al. On the role of melatonin in skin physiology and pathology. Endocrine. 2005;27(2):137-48. doi.org/10.1385/ENDO:27:2:137. PubMed PMID: 16217127. PubMed PMCID: 1317110.
  19. Dreher F, Gabard B, Schwindt DA, Maibach HI. Topical melatonin in combination with vitamins E and C protects skin from ultraviolet-induced erythema: a human study in vivo. Br J Dermatol. 1998;139(2):332-9. doi.org/10.1046/j.1365-2133.1998.02447.x. PubMed PMID: 9767255.
  20. Nickel A, Wohlrab W. Melatonin protects human keratinocytes from UVB irradiation by light absorption. Arch Dermatol Res. 2000;292(7):366-8. doi.org/10.1007/s004030000141. PubMed PMID: 10966062.
  21. Kim BC, Shon BS, Ryoo YW, Kim SP, Lee KS. Melatonin reduces X-ray irradiation-induced oxidative damages in cultured human skin fibroblasts. J Dermatol Sci. 2001;26(3):194-200. doi.org/10.1016/S0923-1811(01)00088-3. PubMed PMID: 11390204.
  22. Ryoo YW, Suh SI, Mun KC, Kim BC, Lee KS. The effects of the melatonin on ultraviolet-B irradiated cultured dermal fibroblasts. J Dermatol Sci. 2001;27(3):162-9. doi.org/10.1016/S0923-1811(01)00133-5. PubMed PMID: 11641055.
  23. Hussein MR, Abu-Dief EE, Abd El-Reheem MH, Abd-Elrahman A. Ultrastructural evaluation of the radioprotective effects of melatonin against X-ray-induced skin damage in Albino rats. Int J Exp Pathol. 2005;86(1):45-55. doi.org/10.1111/j.0959-9673.2005.00412.x. PubMed PMID: 15676032. PubMed PMCID: 2517401.
  24. Fischer TW, Zbytek B, Sayre RM, Apostolov EO, Basnakian AG, Sweatman TW, et al. Melatonin increases survival of HaCaT keratinocytes by suppressing UV-induced apoptosis. J Pineal Res. 2006;40(1):18-26. doi.org/10.1111/j.1600-079X.2005.00273.x. PubMed PMID: 16313494.
  25. Izykowska I, Gebarowska E, Cegielski M, Podhorska-Okolow M, Piotrowska A, Zabel M, et al. Effect of melatonin on melanoma cells subjected to UVA and UVB radiation in In vitro studies. In Vivo. 2009;23(5):733-8. PubMed PMID: 19779108.
  26. Izykowska I, Cegielski M, Gebarowska E, Podhorska-Okolow M, Piotrowska A, Zabel M, et al. Effect of melatonin on human keratinocytes and fibroblasts subjected to UVA and UVB radiation In vitro. In Vivo. 2009;23(5):739-45. PubMed PMID: 19779109.
  27. Cakir ZU, Demirel C, Ugurlu P, Saruhan BG, Ketani S, Seker U, et al. Radio-Protective Effects of Melatonin on the Skin Histology in the Rat. Journal of International Dental and Medical Research. 2014;7(3):73.
  28. Janjetovic Z, Nahmias ZP, Hanna S, Jarrett SG, Kim TK, Reiter RJ, et al. Melatonin and its metabolites ameliorate ultraviolet B-induced damage in human epidermal keratinocytes. J Pineal Res. 2014;57(1):90-102. doi.org/10.1111/jpi.12146. PubMed PMID: 24867336. PubMed PMCID: 4106994.
  29. Ozguner F, Aydin G, Mollaoglu H, Gokalp O, Koyu A, Cesur G. Prevention of mobile phone induced skin tissue changes by melatonin in rat: an experimental study. Toxicol Ind Health. 2004;20:133-9. doi.org/10.1191/0748233704th207oa. PubMed PMID: 15941010.
  30. Watson RR. Melatonin in the Promotion of Health: CRC Press; 2011.
  31. Yasuo S, Nakao N, Ohkura S, Iigo M, Hagiwara S, Goto A, Ando H, Yamamura T, Watanabe M, Watanabe T, Oda S, Maeda K, Lincoln GA, Okamura H, Ebihara S, Yoshimura T. Long-day suppressed expression of type 2 deiodinase gene in the mediobasal hypothalamus of the Saanen goat, a short-day breeder: implication for seasonal window of thyroid hormone action on reproductive neuroendocrine axis. Endocrinology. 2006;147(1):432-40. PubMed PMID: 16195409.